Drugs / Convalescent Serum
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT04349410 | Apr → Sep 2020 | COVID-19 | The Camelot Foundation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Convalescent Serum | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04349410 ↗ |
| Route | Intravenous | “Each unit intravenously infused over 4-hours.” NCT04349410 ↗ |